OmniAb, Inc. Common Stock
Symbol: OABI (NASDAQ)
1.65
▲ (2.48%) 0.040
Company Description:
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
Key Stats
- Today's Open: $1.62
- Today's High: $1.715
- Today's Low: $1.593
- Today's Volume: 791.30K
- Yesterday Close: $1.61
- Yesterday High: $1.66
- Yesterday Low: $1.58
- Yesterday Volume: 1.52M
- Last Min Volume: 67
- Last Min High: $1.65
- Last Min Low: $1.65
- Last Min VWAP: $1.65
Company Profile
- Name: OmniAb, Inc. Common Stock
- Website: https://www.omniab.com
- Listed Date: 2022-11-01
- Location: EMERYVILLE, CA
- Market Status: Active
- CIK Number: 0001846253
- SIC Code: 8731
- SIC description: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
- Market Cap: $231.77M
- Round Lot: 100
- Outstanding Shares: 143.96M
- Asset Type: CS
RECENT FILINGS FOR OABI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-19 | EFFECT | View |
| 2025-09-12 | S-3 | View |
| 2025-09-10 | D | View |
| 2025-08-27 | SCHEDULE 13G/A | View |
| 2025-08-26 | 4 | View |
| 2025-08-25 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-01 | SCHEDULE 13G | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 8-K | View |
| 2025-06-06 | SCHEDULE 13G | View |
| 2025-05-15 | 4 | View |
Latest News on OABI